Multiple bullish signals on ACW. Big chart gap to fill @6.5Very positive signals on MACD and DMI . Momentum building nicely
Big chart gap to fill at 6,5c offering a 60% gain in shareprice.
A lot of consolidation has taken place below 3c in past 5 months removing the surplus overhang of shares from the previous capital raising.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.003 AUD
−13.04 M AUD
0.00 AUD
2.67 B
About ACTINOGEN MEDICAL LIMITED
Sector
Industry
CEO
Steven G. Gourlay
Website
Headquarters
Sydney
Founded
1999
ISIN
AU000000ACW3
FIGI
BBG000PS5K82
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.
Finer Market Points: ASX Top 10 Momentum Stocks: 16 Jul 2024ASX:I88 NYSE:WTM ASX:AL3 XETR:DGR ASX:FBR ASX:ACW AMEX:TTT GETTEX:SKS ASX:3DP ASX:EZZ
Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appear
Shares in ACW are this morning trading up over 200%Shares in ACW are this morning trading up over 200% from their closing price yesterday. The company released an update regarding their Xanamem product.
The key points the company focused on in the release were.
- Statistically significant results demonstrate cognitive improvement in healthy elderl
ACW UpdateOn the daily and weekly both charts on the MACD show some south ,movement while I was pasting up the head and shoulders.
I will be looking for a good buy in a day or two to jump on the ride north as soon as MACD start to show a change.
Looking for Tips and education so feel free to comment.
ACW possible reversal.ACW has put in the early stages of a reversal. Low rejected on good volume. Next few days will confirm this possible reversal. Good FA and expectation of results mid year should provide a good catalyst.
It appears some value is being seen at current share price. Interesting one to follow.
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ACW is 0.030 AUD — it has increased by 3.45% in the past 24 hours. Watch ACTINOGEN MEDICAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ACTINOGEN MEDICAL LIMITED stocks are traded under the ticker ACW.
ACW stock has fallen by −3.23% compared to the previous week, the month change is a −6.25% fall, over the last year ACTINOGEN MEDICAL LIMITED has showed a 1.39% increase.
ACW stock is 7.14% volatile and has beta coefficient of 0.23. Track ACTINOGEN MEDICAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is ACTINOGEN MEDICAL LIMITED there?
Yes, you can track ACTINOGEN MEDICAL LIMITED financials in yearly and quarterly reports right on TradingView.
ACTINOGEN MEDICAL LIMITED is going to release the next earnings report on Aug 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ACW net income for the last half-year is −8.17 M AUD, while the previous report showed −1.49 M AUD of net income which accounts for −449.13% change. Track more ACTINOGEN MEDICAL LIMITED financial stats to get the full picture.
No, ACW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACTINOGEN MEDICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACTINOGEN MEDICAL LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACTINOGEN MEDICAL LIMITED stock shows the sell signal. See more of ACTINOGEN MEDICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.